Gower A J, Tricklebank M D
Merrell Dow Research Centre, Strasbourg, France.
Eur J Pharmacol. 1988 Oct 11;155(1-2):129-37. doi: 10.1016/0014-2999(88)90410-4.
The anxiolytic effects of buspirone, its metabolite, 1-(2-pyrimidyl)piperazine (1-PP) and several alpha 2-adrenoceptor antagonists have been compared in an anticonflict (shock-induced suppression of drinking) paradigm in rats. Idazoxan, WY 26392 and yohimbine had anticonflict effects comparable to those of buspirone and 1-PP, and enhanced the release of suppressed responding induced by buspirone. The response to buspirone was antagonised by the alpha 2-adrenoceptor agonist clonidine. In tests of clonidine-induced mydriasis, the antagonist potencies of buspirone, 1-PP, idazoxan, WY 26392 and yohimbine corresponded closely to the doses of the compounds active in the anticonflict test. Clonidine-induced hypolocomotion was also antagonised by 1-PP, although this response was potentiated by buspirone. The results suggest that the anticonflict effects of buspirone involve an alpha 2-adrenoceptor mechanism.
在大鼠的抗冲突(电击诱导饮水抑制)模型中,比较了丁螺环酮、其代谢产物1-(2-嘧啶基)哌嗪(1-PP)以及几种α2-肾上腺素能受体拮抗剂的抗焦虑作用。咪唑克生、WY 26392和育亨宾具有与丁螺环酮和1-PP相当的抗冲突作用,并增强了丁螺环酮诱导的被抑制反应的释放。丁螺环酮的反应被α2-肾上腺素能受体激动剂可乐定拮抗。在可乐定诱导散瞳的试验中,丁螺环酮、1-PP、咪唑克生、WY 26392和育亨宾的拮抗效力与在抗冲突试验中具有活性的化合物剂量密切对应。1-PP也拮抗可乐定诱导的运动减少,尽管丁螺环酮增强了这种反应。结果表明,丁螺环酮的抗冲突作用涉及α2-肾上腺素能受体机制。